Announce Date | 08/07/2025 |
EPS Normalized Actual | $0.6 (Beat by $0.08) |
EPS GAAP Actual | $0.6 (Beat by $0.08) |
Revenue Actual | $0.254308B |
Revenue Surprise | Beat by $254.308M |
Announce Date | 09/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0.58333 |
EPS GAAP Estimate | $0.58333 |
Revenue Estimate | $0.2514016B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 0 | INF | 0 | 0 | 0 |
Dec 2027 | 0 | INF | 0 | 0 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 0.69 | 0.69 | 0.254308B | 8.06% | 254.31M |
FQ1 2025 (Feb 2025) | 0.56 | 0.56 | 0.238822B | 6.51% | 238.82M |
FQ4 2024 (Dec 2024) | 0.61 | 0.61 | 0.24224B | 6.61% | 242.24M |
FQ3 2024 (Sep 2024) | 0.74 | 0.74 | 0.240497B | 7.75% | 240.5M |
FQ2 2024 (Jun 2024) | 0.67 | 0.67 | 0.233807B | 100% | 233.81M |
FQ1 2013 (Mar 2013) | -1.86 | -1.86 | 0.028029B | 100% | 28.03M |
FQ2 2013 (Jun 2013) | 1.03 | 1.03 | 0.032538B | 100% | 32.54M |
FQ3 2013 (Sep 2013) | -0.0155 | -0.0155 | 0.0348275B | 100% | 34.83M |
FQ4 Announce Date
09/30/2025 (Pre-Market)
Consensus EPS Estimates
0.58333
Consensus Revenue Estimates
0.2514016B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.6962 | -- | 0.68119 | 0.71257 | 2 |
FQ3 2027 (Sep 2027) | 0.7172 | -- | 0.70174 | 0.73406 | 2 |
FQ2 2027 (Jun 2027) | 0.64 | -- | 0.6262 | 0.65505 | 2 |
FQ1 2027 (Mar 2027) | 0.61 | -- | 0.59685 | 0.62434 | 2 |
FQ4 2026 (Nov 2026) | 0.64 | -- | 0.64 | 0.64 | 2 |
FQ3 2026 (Aug 2026) | 0.645 | -- | 0.645 | 0.645 | 2 |
FQ2 2026 (May 2026) | 0.58 | -18.97 | 0.58 | 0.58 | 2 |
FQ1 2026 (Feb 2026) | 0.57 | 1.75 | 0.57 | 0.57 | 2 |
FQ4 2025 (Oct 2025) | 0.6 | -1.67 | 0.59397 | 0.6058 | 2 |
FQ3 2025 (Sep 2025) | 0.58333 | -26.86 | 0.57067 | 0.59651 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.26B | -- | 0.26B | 0.27B | 2 |
FQ3 2027 (Sep 2027) | 0.27B | -- | 0.26B | 0.27B | 2 |
FQ2 2027 (Jun 2027) | 0.27B | -- | 0.27B | 0.27B | 2 |
FQ1 2027 (Mar 2027) | 0.26B | -- | 0.25B | 0.26B | 2 |
FQ4 2026 (Nov 2026) | 0.26B | -- | 0.26B | 0.26B | 3 |
FQ3 2026 (Aug 2026) | 0.26B | -- | 0.26B | 0.26B | 3 |
FQ2 2026 (May 2026) | 0.25B | -0.05 | 0.25B | 0.25B | 3 |
FQ1 2026 (Feb 2026) | 0.25B | 4.23 | 0.25B | 0.25B | 3 |
FQ4 2025 (Oct 2025) | 0.25B | 1.88 | 0.24B | 0.25B | 1 |
FQ3 2025 (Sep 2025) | 0.25B | 4.34 | 0.25B | 0.26B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 0.69 | 0.69 | 100% | |
FQ1 2025 (Feb 2025) | 0.56 | 0.56 | 100% | |
FQ4 2024 (Dec 2024) | 0.61 | 0.61 | 100% | |
FQ3 2024 (Sep 2024) | 0.74 | 0.74 | 100% | |
FQ2 2024 (Jun 2024) | 0.67 | 0.67 | 100% | |
FQ1 2013 (Mar 2013) | -1.86 | -1.86 | 100% | |
FQ2 2013 (Jun 2013) | 1.03 | 1.03 | 100% | |
FQ3 2013 (Sep 2013) | -0.0155 | -0.0155 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $0B | $0.25B | $254.31M | 100% |
FQ1 2025 (Feb 2025) | $0B | $0.24B | $238.82M | 100% |
FQ4 2024 (Dec 2024) | $0B | $0.24B | $242.24M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.24B | $240.5M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.23B | $233.81M | 100% |
FQ1 2013 (Mar 2013) | $0B | $0.03B | $28.03M | 100% |
FQ2 2013 (Jun 2013) | $0B | $0.03B | $32.54M | 100% |
FQ3 2013 (Sep 2013) | $0B | $0.03B | $34.83M | 100% |